Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Contract Win

29 May 2008 07:00

RNS Number : 4618V
ViaLogy PLC
29 May 2008
 



ViaLogy SPM powers Axia NetMedia Air Quality Monitoring Managed Service Prototype for the Alberta SuperNet

Managed Services approach to broad area emissions tracking and compliance for public sector and commercial enterprises.

 

PASADENAMay 29, 2008 - ViaLogy PLC (LSE: VIYannounces it has signed a contract to deploy SPM™ (Sensor Policy Manager™) as a prototype managed services delivery platform on the Alberta SuperNet with Axia NetMedia Corporation. This first joint offering would deliver an environmental air quality monitoring and compliance tracking proof of concept targeted at government and industry customersAxia and ViaLogy will initially roll out this service at two remote points of presence (POPs) in Alberta. Upon successful demonstration, Axia could scale the pilot to over 100 additional POPs and provide real-time emissions assessment, surveillance and alert information in support of various air quality monitoring, compliance and reporting initiatives

By offering this information in a managed services environment, Axia could significantly lower capital investment and operational costs and provide reliable information for its Supernet customer base. The model has the potential to be offered by Axia to other jurisdictions where it operates Next Generation Networks. Recently, there have been a host of regulations for ambient air quality standards, emissions standards and monitoring methods in Alberta. In fact, nationwide, nearly half of Canada's greenhouse gas (GHG) pollution comes from large industrial facilities in sectors like oil and gas, electricity generation and chemicals. This managed services offering would provide broad area ambient air quality visibility to regulators and optimize response and remediation measures.

Axia (www.axia.complans, designs, develops and operates ultra-high-performance, Real Broadband™ Open Access Networks that provide uncompromised connectivity in and between both large and small markets worldwide. As a core technology platform for a managed services solution, ViaLogy will provide the sensor integration engine for the platform. ViaLogy's SPM™ software enables disparate sensors in very large enterprise networks to process and report only key events of interest to security personnel. The ViaLogy technology is sensor agnostic and considerably enhances the performance and strength of all integrated legacy and IP sensors, thus avoiding false alarms, missed events and optimizing use of limited bandwidth. 

"We are pleased to be working with ViaLogy as part of this next generation managed services proof of concept." said Mark Blake, Axia's Vice President, Marketing and Business Development. "Our strategy here is to pull together various environmental sensor data to provide our customers with consistent, reliable air quality measurements in a managed services environment. SPM's ability to offer scaleable sensor-based services for safety, security, remote monitoring and business continuity is central to our service.

"Axia has chosen SPM™ to address a worldwide requirement from customers for improved and coordinated integrated sensor data in a managed services environment," said Robert W. Dean. President and CEO of ViaLogy, "We are proud to be chosen for the initial pilot and for potential future deployments worldwide. As Axia's partner, Vialogy expects to gain access to major sales opportunities globally. 

"SPM™ is a comprehensive and flexible product that can be customized to suit individual customer needs because we recognize that there are a variety of situations to be dealt with. Some customers will want a turnkey networked system for monitoring a new building or campuswhile others will want the integration of their existing sensors and new sensor arrangements. 

"The Axia-Vialogy solution will provide consistent, integrated and reliable environmental sensor data."

 

- Ends -

 

Further information from:

 

ViaLogy

Robert W Dean, President/CEO - US  +1 626-296-6337 

(mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe  +44 (0)1235 834734

Nominated Advisor (Seymour Pierce)

Mark Percy  +44 (0)20 7107 8000

PR Consultants - Redleaf Communications

Samantha Robbins / Anna Dunkin +44 (0)20 7822 0200

About ViaLogy: Network Centric Signal Processing.

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications and sensor fusion. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. Vialogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.vialogy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEAFWASASEFI
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.